Measles-Mumps-Rubella Vaccine
"Measles-Mumps-Rubella Vaccine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A combined vaccine used to prevent MEASLES; MUMPS; and RUBELLA.
Descriptor ID |
D022542
|
MeSH Number(s) |
D20.215.894.815.500 D20.215.894.899.404.500 D20.215.894.899.488.500 D20.215.894.899.779.500
|
Concept/Terms |
Measles-Mumps-Rubella Vaccine- Measles-Mumps-Rubella Vaccine
- Measles Mumps Rubella Vaccine
- Vaccine, Measles-Mumps-Rubella
- Measles, Mumps, Rubella Vaccine
- MMR Vaccine
- Vaccine, MMR
- Mumps-Measles-Rubella Vaccine
- Mumps Measles Rubella Vaccine
- Vaccine, Mumps-Measles-Rubella
|
Below are MeSH descriptors whose meaning is more general than "Measles-Mumps-Rubella Vaccine".
Below are MeSH descriptors whose meaning is more specific than "Measles-Mumps-Rubella Vaccine".
This graph shows the total number of publications written about "Measles-Mumps-Rubella Vaccine" by people in this website by year, and whether "Measles-Mumps-Rubella Vaccine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 0 | 1 | 1 |
2019 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Measles-Mumps-Rubella Vaccine" by people in Profiles.
-
Morales CG, Jimenez NR, Herbst-Kralovetz MM, Lee NR. Novel Vaccine Strategies and Factors to Consider in Addressing Health Disparities of HPV Infection and Cervical Cancer Development among Native American Women. Med Sci (Basel). 2022 09 13; 10(3).
-
Ashford JW, Gold JE, Huenergardt MA, Katz RBA, Strand SE, Bolanos J, Wheeler CJ, Perry G, Smith CJ, Steinman L, Chen MY, Wang JC, Ashford CB, Roth WT, Cheng JJ, Chao S, Jennings J, Sipple D, Yamamoto V, Kateb B, Earnest DL. MMR Vaccination: A Potential Strategy to Reduce Severity and Mortality of COVID-19 Illness. Am J Med. 2021 02; 134(2):153-155.
-
Perelygina L, Chen MH, Suppiah S, Adebayo A, Abernathy E, Dorsey M, Bercovitch L, Paris K, White KP, Krol A, Dhossche J, Torshin IY, Saini N, Klimczak LJ, Gordenin DA, Zharkikh A, Plotkin S, Sullivan KE, Icenogle J. Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies. PLoS Pathog. 2019 10; 15(10):e1008080.
-
Perez EE, Bokszczanin A, McDonald-McGinn D, Zackai EH, Sullivan KE. Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Pediatrics. 2003 Oct; 112(4):e325.